June 2, 2025 Kigali, Rwanda and San Francisco, USA

We at Bio Usawa extend our warmest wishes for success to Dr. Amadou Sall, as he starts his new position as Executive Director, Manufacturing  and Supply Chain, with the Coalition for Epidemic Preparedness Innovation (CEPI). 

Dr. Sall transitions to his new position following his transformational work with the Institut Pasteur de Dakar in Senegal. At CEPI, he will lead the manufacturing and supply chain strategy focusing on underserved regions, with the goal of improving the speed, scale and accessibility of vaccine production. Bio Usawa shares these important goals especially with regard to biosimilar therapies for ophthalmology, oncology, immunology and infectious disease. 

Congratulations on your first day, Dr. Sall!

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.